45 results on '"Yzet, Clara"'
Search Results
2. Non-invasive evaluation of mucosal healing by intestinal ultrasound or fecal calprotectin is efficient in Crohn's disease: A cross-sectional study
3. Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression
4. Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: A Multicenter Cohort Study
5. Positive margins and plexitis increase the risk of recurrence after ileocecal resection: A systematic review and meta-analysis
6. Endoscopic submucosal dissection of appendicular lesions is feasible and safe: a retrospective multicenter study (with video)
7. Is there concordance between the Cellvizio system and pathology in determining microscopic inflammation at the ileal resection margins in Crohn's ileal disease? The CELLVICROHN study
8. Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study
9. Complete endoscopic healing is associated with lower disability than partial endoscopic healing in Crohn's disease: A prospective multicenter study
10. Endoscopic balloon dilation of colorectal strictures complicating Crohn’s disease: a multicenter study
11. Positive histologic margins is a risk factor of recurrence after ileocaecal resection in Crohn’s disease
12. No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-analysis
13. Inflammatory bowel disease symptoms at the time of anal fistula lead to the diagnosis of Crohn's disease
14. Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn’s Disease
15. Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease
16. Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial
17. Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes
18. Premedication as primary prophylaxis does not influence the risk of acute infliximab infusion reactions in immune-mediated inflammatory diseases: A systematic review and meta-analysis
19. Mo1814 PREVALENCE, ETIOLOGY AND OUTCOME OF ACUTE PANCREATITIS IN INFLAMMATORY BOWEL DISEASE: EUROPEAN PANDORA STUDY
20. Sa1796 OPTIMAL ENDOSCOPIC HEALING THRESHOLDS DEFINED BY MM-SES-CD < 22.5 AND SES-CD
21. ENDOSCOPIC SUBMUCOSAL DISSECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS FOR VISIBLE DYSPLASIA: A FRENCH RETROSPECTIVE MULTICENTRIC STUDY
22. ENDOSCOPIC SUBMUCOSAL DISSECTION OR FULL-THICKNESS RESECTION DEVICE TO TREAT RECURRENT OR RESIDUAL NEOPLASIA AFTER ENDOSCOPIC RESECTION: A MULTICENTER HISTORICAL COHORT STUDY
23. WHAT IS THE DIFFERENCE IN OUTCOMES BETWEEN THE ESD OF LARGE COLONIC AND RECTAL LESIONS? FRENCH MULTICENTER PROSPECTIVE COHORT OF 3901 PROCEDURES (FECCO- NCT04592003)
24. ENDOSCOPIC SUBMUCOSAL DISSECTION OR FULL-THICKNESS RESECTION DEVICE TO TREAT RECURRENT OR RESIDUAL NEOPLASIA AFTER ENDOSCOPIC RESECTION: A MULTICENTER HISTORICAL COHORT STUDY
25. Mo1742 ULTRASOUND IS EFFECTIVE TO IDENTIFY MUCOSAL HEALING IN CROHN'S DISEASE PATIENTS : RESULTS OF A CROSS-SECTIONAL STUDY
26. 1142 TRANSMURAL HEALING IS NOT ASSOCIATED WITH LESS DISABILITY THAN COMPLETE ENDOSCOPIC MUCOSAL HEALING: A PROSPECTIVE STUDY IN A PATIENT WITH CROHN'S DISEASE
27. 718: EVOLUTION OF CLINICAL AND PHARMACOLOGICAL PARAMETERS AFTER SWITCHING FROM INTRA-VENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE : THE REMSWITCH STUDY
28. Reply
29. Reply
30. Su1912 CDEIS SCORE OF 2 IS OPTIMAL CUT-OFF ASSOCIATED WITH LOWER RISK OF DISEASE PROGRESSION IN EARLY CROHN'S DISEASE: DATA FROM THE CALM STUDY
31. Sa1788 LOW LEVELS OF VITAMIN D AND OSTEOPENIA ARE COMMON IN ULCERATIVE COLITIS PATIENTS AFTER TOTAL PROCTOCOLECTOMY WITH ILEAL POUCH ANAL ANASTOMOSIS
32. Tu2043 – Efficacy and Safety of Percutaneous Rendez-Vous Technique After Failed Ercp for Malignant Biliary Obstruction
33. Mo1942 – Clostridium Difficile of the Ileal Pouch Anal Anastomosis – Incidence, Risk Factors, and Outcomes
34. Mo1899 – Prognostic Factors for Long-Term Adalimumab Treatment in Crohn’s Disease : A Multicenter Experience
35. Mo1844 – Long-Term Fate of the Excluded Rectum in Crohn’s Disease
36. Mo1826 – Hold the Mayo, are Endoscopists Taking Histology in Stride? Discordance Among Endoscopic Activity and Histologic Findings in Ulcerative Colitis
37. Mo1806 – Endoscopic Pouch Activity in Asymptomatic Patients with an Ileal Pouch Anal Anastomosis is Associated with an Increased Risk of Future Pouchitis
38. Sa1812 – Endoscopic and Deep Remission At 1 Year Prevents Disease Progression in Early Crohn's Disease: Long-Term Data from Calm
39. Sa1813 – Cuffitis is Associated with a Significant Risk of Ileal Pouch Anal Anastomosis Failure
40. 705 – Pre-Operative Biologics Significantly Reduce Post-Operative Leaks After Staged Restorative Proctocolectomy
41. 110 – Stopping 5-Aminosalicylates in Crohn's Disease Patients Starting Biologic Therapy Does Not Increase the Risk of Adverse Clinical Outcomes: Analysis of Two Nationwide Population-Based Cohorts
42. Tu1714 - What is the Risk of Crohn's Disease in Patients with Anal Fistula Surgery?
43. Su1891 - Long-Term Natural History of Microscopic Colitis: A Population-Based Study
44. Mo1868 - Evaluation of the Diagnostic and Prognostic Value of Procalcitonin in Acute Colitis
45. 1126 - What is the Best definition of Mucosal Healing in Crohn Disease?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.